Elijah Ogola is an expert in Cardiology at Kenyatta National Hospital (Kenya). As of October 2026, ScienceLeadR ranks Elijah Ogola in the top 1% of experts in Kenya for Coronary Disease, Myocardial Ischemia and Heart Failure. Elijah Ogola has authored 118 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 367 (community average: 125). How the SLR is computed.

LeadR Profile

Elijah Ogola Kenyatta National Hospital Kenya
367 ScienceLeadR Reputation 367
Network Map

Cardiology

Subspecialties: Public Health - Biostatistics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University of Nairobi

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 118

Citations

Citations: 3 362 1st author: 12 Last author: 20 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prevalence of target organ damage in rural Kenya and The Gambia: a cross-sectional study.
PMID 42729214 — hypertension, cross-sectional studies, prevalence
Lancet Reg Health Afr20260
Preventing cardiovascular disease in Africa: complexity, community, and the case for local solutions.
PMID 42696348 — cardiovascular diseases, solutions
Eur J Prev Cardiol20260
Triple drug antihypertensive single-pill combinations included as WHO essential medicines: an overview of efficacy, safety, and cost.
PMID 42595774 — hypertension, safety, pharmaceutical preparations, antihypertensive agents, therapeutics, single-pill combination
J Hum Hypertens20260
2026 ISH guidelines for the management of hypertension in Africa: the International Society of Hypertension (ISH) African Regional Advisory Group and the Pan African Society of Cardiology (PASCAR).
PMID 42554264 — hypertension, cardiovascular diseases, blood pressure, cardiology, hiv, angiotensin receptor antagonists, physicians, mineralocorticoid receptor antagonists, single-pill combination
J Hypertens20260
Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions - insights from the INTERASPIRE study.
PMID 42395097 — risk assessment, heart, cholesterol, physicians, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Am J Prev Cardiol20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 2
N/A 1
Phase 4 1

By status:

Completed 2
Recruiting 1
Unknown 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Remote Ischaemic Conditioning in STEMI Patients in AFRICA
NCT04813159 — mortality, blood, myocardial infarction, heart failure, heart, blood pressure, myocardial reperfusion injury, inflation, economic, st elevation myocardial infarction, reperfusion, reperfusion injury, myocardial reperfusion, conditioning, psychological, ischemia
N/ARecruiting2022

LeadR Networks

Main global connection map